• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术后确定的甲状腺乳头状癌高危组织病理学特征:改变游戏规则的因素。

Postoperatively determined high-risk histopathologic features in papillary thyroid carcinoma initially eligible for thyroid lobectomy: a game changer.

机构信息

Department of General and Specialized Surgery, Faculty of Medicine, the Hashemite University, Zarqa, 13133, Jordan.

Department of General and Endocrine Surgery, University of Poitiers, CHU Poitiers, Poitiers, France.

出版信息

Endocrine. 2021 Dec;74(3):611-615. doi: 10.1007/s12020-021-02788-w. Epub 2021 Jun 10.

DOI:10.1007/s12020-021-02788-w
PMID:34110601
Abstract

PURPOSE

Recent clinical practice guidelines consider thyroid lobectomy a viable alternative for low-risk papillary thyroid carcinoma PTC measuring 1-4 cm in size. We aimed to assess the likelihood of finding postoperatively determined high-risk histopathologic features that would lead to the recommendation of completion thyroidectomy.

METHODS

A retrospective review of patients who underwent total thyroidectomy for PTC measuring 1-4 cm in size between Jan 2012 and Jan 2018 was conducted. Patients with pre-operative high-risk characteristics were excluded: history of radiation exposure, positive family history, clinically suspicious cervical lymphadenopathy, and gross extrathyroidal extension (ETE). A hypothetical group of 245 patients remained eligible for lobectomy. The pathology specimens from the cancer-containing lobes were evaluated for high-risk features: aggressive histology, capsular and/or vascular invasion, microscopic ETE, and multifocality. A subgroup analysis was performed with 2 cm being the cut-off size.

RESULTS

The average age was 39 years with 73% being females. Mean cancer size was 16 mm. Evaluation of the cancer-containing lobe for high-risk features revealed: aggressive histology (33%), ETE (12%), capsular invasion (33%), vascular invasion (17%), and ipsilateral multifocality (30%). The cumulative risk of having ≥1 high-risk feature mandating completion thyroidectomy was 59%. The risk was considerably higher for lesions ≤2 cm compared to larger lesions (64% vs.48%; p = 0.049; RR = 1.3).

CONCLUSIONS

A considerable proportion of patients initially eligible for lobectomy have high-risk features that only become evident at pathology. Therefore, a comprehensive approach is advocated to determine the extent of surgery for PTC incorporating patient preferences regarding risks and benefits.

摘要

目的

最近的临床实践指南认为,对于 1-4cm 大小的低危甲状腺乳头状癌(PTC),甲状腺叶切除术是一种可行的替代方案。我们旨在评估术后确定的高危组织病理学特征的可能性,这些特征将导致推荐行甲状腺全切除术。

方法

对 2012 年 1 月至 2018 年 1 月期间行甲状腺全切除术治疗 1-4cm 大小的 PTC 的患者进行回顾性研究。排除术前具有高危特征的患者:辐射暴露史、阳性家族史、临床可疑的颈部淋巴结肿大和大体甲状腺外侵犯(ETE)。有 245 例患者符合行甲状腺叶切除术的条件。评估含癌叶的病理标本是否存在高危特征:侵袭性组织学、包膜和/或血管侵犯、镜下 ETE 和多灶性。以 2cm 为截点进行亚组分析。

结果

患者平均年龄为 39 岁,女性占 73%。平均癌症大小为 16mm。评估含癌叶的高危特征发现:侵袭性组织学(33%)、ETE(12%)、包膜侵犯(33%)、血管侵犯(17%)和同侧多灶性(30%)。需要行甲状腺全切除术以治疗至少 1 个高危特征的累积风险为 59%。≤2cm 的病变与较大病变相比,具有高危特征的风险更高(64% vs. 48%;p=0.049;RR=1.3)。

结论

相当一部分最初符合甲状腺叶切除术条件的患者具有高危特征,这些特征仅在病理检查时才变得明显。因此,提倡采用综合方法来确定甲状腺癌手术范围,综合考虑患者对风险和获益的偏好。

相似文献

1
Postoperatively determined high-risk histopathologic features in papillary thyroid carcinoma initially eligible for thyroid lobectomy: a game changer.术后确定的甲状腺乳头状癌高危组织病理学特征:改变游戏规则的因素。
Endocrine. 2021 Dec;74(3):611-615. doi: 10.1007/s12020-021-02788-w. Epub 2021 Jun 10.
2
Individualizing Surgery in Papillary Thyroid Carcinoma Based on a Detailed Sonographic Assessment of Extrathyroidal Extension.基于甲状腺外侵犯的详细超声评估对甲状腺乳头状癌进行个体化手术。
Thyroid. 2017 Dec;27(12):1544-1549. doi: 10.1089/thy.2017.0457.
3
Frequency of High-Risk Characteristics Requiring Total Thyroidectomy for 1-4 cm Well-Differentiated Thyroid Cancer.1-4厘米分化型甲状腺癌需行全甲状腺切除术的高危特征发生率
Thyroid. 2016 Jun;26(6):820-4. doi: 10.1089/thy.2015.0495. Epub 2016 May 20.
4
Significance of multifocality in papillary thyroid carcinoma.多灶性在甲状腺乳头状癌中的意义。
Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1820-1828. doi: 10.1016/j.ejso.2020.06.015. Epub 2020 Jun 19.
5
Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis.对于多灶性、血管淋巴管浸润、甲状腺外延伸至颈阔肌、或 5 个或更多中央淋巴结微转移的甲状腺乳头状癌,可能不需要完成甲状腺切除术。
Oral Oncol. 2022 Nov;134:106115. doi: 10.1016/j.oraloncology.2022.106115. Epub 2022 Sep 12.
6
Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.半甲状腺切除术治疗微小甲状腺外侵犯的甲状腺乳头状癌的疗效。
Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3435-3442. doi: 10.1007/s00405-019-05598-z. Epub 2019 Aug 14.
7
Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features.对于直径1至4厘米且无临床可识别高危特征的乳头状甲状腺癌,肺叶切除术比全甲状腺切除术更具成本效益。
Ann Surg Oncol. 2016 Oct;23(11):3641-3652. doi: 10.1245/s10434-016-5280-6. Epub 2016 May 24.
8
The utility of intra-operative frozen section for the evaluation of microscopic extrathyroidal extension in papillary thyroid carcinoma.术中冰冻切片在评估甲状腺乳头状癌镜下甲状腺外侵犯中的应用。
Clin Otolaryngol. 2017 Dec;42(6):1167-1171. doi: 10.1111/coa.12843. Epub 2017 Feb 26.
9
Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.甲状腺叶切除术治疗甲状腺乳头状癌:1088 例长期随访研究。
World J Surg. 2014 Jan;38(1):68-79. doi: 10.1007/s00268-013-2224-1.
10
Prognosis of Patients with 1-4 cm Papillary Thyroid Cancer Who Underwent Lobectomy: Focus on Gross Extrathyroidal Extension Invading Only the Strap Muscles.1-4cm 甲状腺乳头状癌患者行 lobectomy 后的预后:重点关注仅侵犯带状肌的大体甲状腺外侵犯。
Ann Surg Oncol. 2022 Nov;29(12):7835-7842. doi: 10.1245/s10434-022-12155-2. Epub 2022 Jul 30.

引用本文的文献

1
Risk characteristics of papillary thyroid cancer > 1-4 cm is associated with increased tumour size.直径大于1至4厘米的甲状腺乳头状癌的风险特征与肿瘤大小增加有关。
Clin Exp Med. 2025 May 12;25(1):155. doi: 10.1007/s10238-025-01596-0.
2
Verifying the oncologic rationale of prophylactic central compartment neck dissection in the management of papillary thyroid carcinoma using a pathologic spectrum of nodal metastases characteristics. A Prospective Comparative study.利用淋巴结转移特征的病理谱验证预防性中央区颈清扫术在甲状腺乳头状癌治疗中的肿瘤学理论依据。一项前瞻性对照研究。
Endocrine. 2025 Jul;89(1):119-124. doi: 10.1007/s12020-025-04209-8. Epub 2025 Mar 1.
3

本文引用的文献

1
Impact of COVID-19 on thyroid cancer surgery and adjunct therapy.COVID-19 对甲状腺癌手术和辅助治疗的影响。
Updates Surg. 2020 Sep;72(3):867-869. doi: 10.1007/s13304-020-00833-3. Epub 2020 Jun 14.
2
Energy-based devices in thyroid surgery-an overview.甲状腺手术中基于能量的设备——综述
Gland Surg. 2020 Jan;9(Suppl 1):S14-S17. doi: 10.21037/gs.2019.08.05.
3
Surgical Management of Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma. Experience in 25 Patients.弥漫硬化型甲状腺乳头状癌的外科治疗。25 例经验总结。
Restratification of intermediate risk factors on the recurrence of papillary thyroid carcinoma: a retrospective cohort study.
甲状腺乳头状癌复发的中间风险因素再分层:一项回顾性队列研究
Int J Surg. 2025 Jan 1;111(1):884-890. doi: 10.1097/JS9.0000000000001945.
4
How good is lobectomy for the Turkish population with papillary thyroid cancer? A clinicopathological evaluation.肺叶切除术对土耳其乳头状甲状腺癌患者的疗效如何?一项临床病理评估。 (注:原文中“lobectomy”一般指肺叶切除术,但这里结合语境看可能是甲状腺叶切除术,译文按甲状腺叶切除术翻译。若原文无误,可追问进一步明确。)
Turk J Surg. 2023 Sep 27;39(3):249-257. doi: 10.47717/turkjsurg.2023.6210. eCollection 2023 Sep.
5
Lobo-isthmectomy in the management of differentiated thyroid cancer.峡部切除术在分化型甲状腺癌治疗中的应用
Thyroid Res. 2023 Feb 13;16(1):4. doi: 10.1186/s13044-022-00145-1.
World J Surg. 2020 Jan;44(1):155-162. doi: 10.1007/s00268-019-05230-5.
4
BRAF mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland.BRAF突变:甲状腺舌管囊肿癌且甲状腺正常患者中超过Sistrunk手术的潜在预测指标。
Updates Surg. 2019 Dec;71(4):701-704. doi: 10.1007/s13304-019-00684-7. Epub 2019 Oct 4.
5
The impact of completion thyroidectomy.全甲状腺切除术的影响。
Eur J Surg Oncol. 2019 Jul;45(7):1171-1174. doi: 10.1016/j.ejso.2019.03.018. Epub 2019 Mar 18.
6
Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.根据甲状腺切除术的范围,1 至 4 厘米分化型甲状腺癌患者的肿瘤学结果。
Head Neck. 2019 Jan;41(1):56-63. doi: 10.1002/hed.25356. Epub 2018 Dec 10.
7
Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?美国癌症联合委员会/肿瘤-淋巴结-转移分期系统(第八版)对分化型和间变性甲状腺癌的更新:有哪些变化及原因?
Thyroid. 2017 Jun;27(6):751-756. doi: 10.1089/thy.2017.0102. Epub 2017 May 19.
8
Surgical management of papillary thyroid carcinoma: an overview.甲状腺乳头状癌的外科治疗:综述
Updates Surg. 2017 Jun;69(2):145-150. doi: 10.1007/s13304-017-0449-5. Epub 2017 Apr 12.
9
Thyroid nodules and cancer management guidelines: comparisons and controversies.甲状腺结节与癌症管理指南:比较与争议
Endocr Relat Cancer. 2017 Feb;24(2):R13-R26. doi: 10.1530/ERC-16-0432. Epub 2016 Dec 13.
10
Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.手术范围对45岁以下甲状腺乳头状癌患者生存的影响。
J Clin Endocrinol Metab. 2015 Jan;100(1):115-21. doi: 10.1210/jc.2014-3039.